HER2
human epidermal growth factor receptor 2
Source: imantsm/medical_abbreviations
Results for
Direct matches for the acronym you searched.
human epidermal growth factor receptor 2
Source: imantsm/medical_abbreviations
Definitions and keywords related to your search.
A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
clinical trial
Source: Wikidata
Study Comparing 4 Cycles With 6 Cycles of TC Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer
clinical trial
Source: Wikidata
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
clinical trial
Source: Wikidata
Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)
clinical trial
Source: Wikidata
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.
clinical trial
Source: Wikidata
A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer
clinical trial
Source: Wikidata
Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
clinical trial
Source: Wikidata
Irinotecan/Capecitabine Versus Capecitabine in Patients Treated With A/T for HER2 Negative Metastatic Breast Cancer
clinical trial
Source: Wikidata
Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.
clinical trial
Source: Wikidata
A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
clinical trial
Source: Wikidata
A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients
clinical trial
Source: Wikidata
TOPAZ: Tucatinib in COmbination With Pembrolizumab And TrastuZumab in Patients With HER2-Positive Breast Cancer Brain Metastases
clinical trial
Source: Wikidata